Overworked and underpaid. - Development Cure SMA Employee Review

2.0
31 Jul 2025
Recommend
CEO approval
Business outlook

Pros

Some of the co-workers were decent.

Cons

Being short staffed creates a lot of pressure.

Explore other reviews about Cure SMA

5.0
31 Aug 2023
Anonymous employee
Recommend
CEO approval
Business outlook

Pros

Mission driven organization with wonderful coworkers!

Cons

I have not found any.

3.0
3 Feb 2024
Anonymous employee
Recommend
CEO approval
Business outlook

Pros

Great co-workers, great opportunity to connect to patients and families, sense of purpose, opportunity to travel, annual conference is incredible

Cons

Executive leadership is some of the worst in the industry and has no fundamental understanding of how to truly improve outcomes and standards of care. High turn over. Toxic. No strategic plan outside of siphoning money from pharma companies for individual personal gain. Tax records are public, money goes to salaries of those favorited. Dont ever express an opinion that goes against the narrative. So many lies told to the community and employees. unethical. Will fire for any reason if you express something that goes against the narrative. Inter company cross collab is awful. Development makes the money and research/clinical care spends all the money. Millions and millions spent with little to show. External marketing and communications are a facade. Covers up failures by termination of employees and points blame. Is not interested in improving or wanting to do the right thing. President and CMO are the worst human beings. If you are even slightly educated, pass on this company and save yourself the headache.

See reviews by: Helpful|Rating|Date|All